Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
about
Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cellsRisk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry.Application of a double-colour upconversion nanofluorescent probe for targeted imaging of mantle cell lymphoma.
P2860
Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Relapsed/refractory pediatric ...... Leukemia/Lymphoma Study Group.
@en
type
label
Relapsed/refractory pediatric ...... Leukemia/Lymphoma Study Group.
@en
prefLabel
Relapsed/refractory pediatric ...... Leukemia/Lymphoma Study Group.
@en
P2093
P2860
P356
P1476
Relapsed/refractory pediatric ...... Leukemia/Lymphoma Study Group
@en
P2093
Akiko M Saito
Atsuko Nakazawa
Masahito Tsurusawa
Naoto Fujita
Ryoji Kobayashi
Tetsuya Mori
P2860
P304
P356
10.1002/PBC.26105
P50
P577
2016-06-17T00:00:00Z